Stocks and Investing Stocks and Investing
Mon, January 20, 2025
[ 07:01 PM ] - Kiplinger
5 Tips for Investing in the Trump Presidency
[ 05:01 PM ] - MSN
Is Nuvalent, Inc. (NUVL) Among Billionaire Joseph Edelman's Long-Term Stock Picks?
[ 05:01 PM ] - Yahoo
Space infrastructure company Redwire to buy Edge Autonomy for $925 million
[ 04:41 PM ] - MSN
3 ASX dividend stocks to buy and hold until 2035
[ 03:41 PM ] - MSN
Is Immatics N.V. (IMTX) Among Billionaire Joseph Edelman's Long-Term Stock Picks?
[ 03:41 PM ] - MSN
Is Artivion, Inc. (AORT) Among Billionaire Joseph Edelman's Long-Term Stock Picks?
[ 03:41 PM ] - MSN
Is Tarsus Pharmaceuticals (TARS) Among Billionaire Joseph Edelman's Long-Term Stock Picks?
[ 03:41 PM ] - Reuters
Focus: Trump Media's true believers bet on stock surge as presidency begins
[ 02:21 PM ] - MSN
Underperform rating for Delivery Hero stock citing competition in Korea and MENA markets
[ 01:41 PM ] - FXStreet
Are banks the new defensive play?
[ 12:41 PM ] - MSN
Here's Some Reassuring News for Anyone Invested in Quantum Computing Stocks
[ 12:41 PM ] - Forbes
Trump's 'Drill Baby Drill' - Why SLB Could Lead Energy Sector In 2025
[ 12:21 PM ] - MSN
Is It Worth Investing in ACM Research (ACMR) Based on Wall Street's Bullish Views?
[ 11:41 AM ] - MSN
Goldman Sachs sees value in diversifying stocks beyond Magnificent 7
[ 11:21 AM ] - MSN
$3.0 trillion in AI capex: could that benefit iDEGEN in 2025?
[ 09:21 AM ] - MSN
AMD: Loop Capital's Buy Rating Reinforces Investor Confidence
[ 09:21 AM ] - BBC
Trump urges US Supreme Court to delay TikTok ban
[ 09:01 AM ] - MSN
2 things that could sink the Lloyds share price in 2025
[ 08:41 AM ] - MSN
2 Reasons I'm Bullish on Uber Stock
[ 08:41 AM ] - Yahoo
Nvidia Stock Has Started 2025 Slowly. Get Used to It.
[ 08:41 AM ] - MSN
3 Subtle Investing Mistakes I Won't Repeat in 2025 And Beyond
[ 08:30 AM ] - WOPRAI
Short squeeze is starting in shares of SLAM at $1 .. 7, after crossing above the $10.197 Trigger Price
[ 08:30 AM ] - WOPRAI
Short squeeze is starting in shares of PKKW at $1 .. 3, after crossing above the $11.503 Trigger Price
[ 08:30 AM ] - WOPRAI
Short squeeze is starting in shares of LIDRW at $ .. 72, after crossing above the $0.071 Trigger Price
[ 08:30 AM ] - WOPRAI
Short squeeze is starting in shares of INCY at $7 .. 5, after crossing above the $72.091 Trigger Price
[ 08:30 AM ] - WOPRAI
Short squeeze is starting in shares of HEAR at $1 .. .15, after crossing above the $17.6 Trigger Price
[ 08:30 AM ] - WOPRAI
Short squeeze is starting in shares of FPI at $11 .. 5, after crossing above the $11.711 Trigger Price
[ 08:30 AM ] - WOPRAI
Short squeeze is starting in shares of CHGCF at $ .. 5, after crossing above the $44.163 Trigger Price
[ 08:30 AM ] - WOPRAI
Short squeeze is starting in shares of ALRN at $2 .. 03, after crossing above the $1.281 Trigger Price
[ 07:41 AM ] - MSN
3 Pieces of Noise to Ignore With Bitcoin, Solana, and Ethereum

Is Tarsus Pharmaceuticals (TARS) Among Billionaire Joseph Edelman's Long-Term Stock Picks?


Published on 2025-01-20 15:41:27 - MSN
  Print publication without navigation

  • We recently published a list of Billionaire Joseph Edelman's Top 10 Long-Term Stock Picks. In this article, we are going to take a look at where Tarsus Pharmaceuticals, Inc. (NASDAQ:TARS) stands against other Billionaire Joseph Edelman's long-term stock picks.

The article from MSN Money discusses whether Tarsus Pharmaceuticals (TARS) is among billionaire Joseph Edelman's long-term stock picks. Tarsus Pharmaceuticals, known for its focus on developing novel therapeutics for ophthalmic conditions, has caught the attention of investors due to its promising pipeline, particularly with its lead candidate TP-03 for the treatment of Demodex blepharitis. The piece highlights Edelman's investment strategy, which often involves backing companies with significant growth potential in niche markets. It notes that while Edelman has invested in Tarsus, the long-term commitment to the stock remains uncertain as his investment decisions can be influenced by various factors including clinical trial outcomes, market conditions, and competitive landscape changes. The article also provides insights into Tarsus's recent developments, financial health, and market performance, suggesting that while there is potential for growth, investors should consider the inherent risks associated with biotech investments.

Read the Full MSN Article at:
[ https://www.msn.com/en-us/money/top-stocks/is-tarsus-pharmaceuticals-tars-among-billionaire-joseph-edelman-s-long-term-stock-picks/ar-AA1xxy2i ]
Contributing Sources